CEAT Limited — Others, 18-03-2025: Appointment

CEAT Limited has announced a board meeting outcome, highlighting key updates: Dr. Santrupt Misra has been appointed as a Non-Executive, Independent Director for a five-year term, pending shareholder approval via Postal Ballot. The Nomination and Remuneration Committee has been restructured to include Dr. Misra. Furthermore, the board approved the CEAT Employees Stock Option Scheme 2025, allowing for the issuance of 4,00,000 options, which will require shareholder consent as well. The adjustments in policies and the substantial increase in capital for the Indonesia subsidiary signal ongoing strategic expansion. This could yield a positive outlook for investors looking at enhancement in governance and employee engagement practices.